Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan and Atorvastatin Drug-Drug Interaction Study
NCT02579356Phase 1Completed
- Sponsor
- Samil Pharmaceutical Co., Ltd.
- Start
- May 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of telmisartan and atorvastatin in essential hypertension and hypercholesterolemia (4 arms), sponsored by Samil Pharmaceutical Co., Ltd. Primary endpoints: Area Under the Curve (AUCt 0-24) at Day 6 and Maximum Steady State Concentration (Css,max) at Day 6. Started May 2014; status: completed.
02
Drugs
telmisartanatorvastatin
03
Conditions
essential hypertensionhypercholesterolemia
Beyond the preview
Go deeper on NCT02579356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02579356.